Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ferozsons LaboratoriesKAR:FEROZ -2.38%70 Pretax Margin % is 7.68% as of Mar. 2026, which is 14% below its 10-year median of 8.89. GuruFocus rates KAR:FEROZ with a GF Score™ of 70/100 and a GF Value™ of ₨419.78 (Fairly Valued). The stock has 4 warning signs investors should review. Among 961 Drug Manufacturers companies, Ferozsons Laboratories ranks better than 55.05% on this metric.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Ferozsons Laboratories Pretax Margin % Related Terms
Ferozsons Laboratories Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Ferozsons Laboratories's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KAR:FEROZ vs ZTS, UTHR, VTRS: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Ferozsons Laboratories's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ferozsons Laboratories Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ferozsons Laboratories's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Ferozsons Laboratories's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ferozsons Laboratories (KAR:FEROZ) has a Pretax Margin % of 7.68% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Ferozsons Laboratories and its competitors. This is 14% below median its historical median of 8.89. Over the past decade, Ferozsons Laboratories' Pretax Margin % has ranged from 1.71 to 25.31. According to the industry distribution chart, Ferozsons Laboratories ranks #432 out of 961 companies in the Drug Manufacturers industry, placing it in the top 45%.
Is Ferozsons Laboratories' Pretax Margin % too high?
Ferozsons Laboratories' current Pretax Margin % of 7.68% is 14% below median its 10-year median of 8.89. Over the past 10 years, this metric has ranged from a low of 1.71 to a high of 25.31. The Drug Manufacturers industry median Pretax Margin % is 7.28. Ferozsons Laboratories' value of 7.68% is 5.5% above this industry median. Based on the distribution chart, Ferozsons Laboratories ranks #432 out of 961 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Ferozsons Laboratories has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ferozsons Laboratories' Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ferozsons Laboratories ranks #432 out of 961 companies for Pretax Margin %. This puts Ferozsons Laboratories in the upper half of its industry. The industry median Pretax Margin % is 7.28. Ferozsons Laboratories' value of 7.68% is 5.5% above this benchmark. Historically, Ferozsons Laboratories' own Pretax Margin % has ranged from 1.71 to 25.31 over the past decade. While the company's 10-year median is 8.89 vs. the industry median of 7.28, Ferozsons Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.28, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ferozsons Laboratories's current Pretax Margin % of 7.68% is 5.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Ferozsons Laboratories and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ferozsons Laboratories's current Pretax Margin % is 7.68%, which is 14% below median its own 10-year median of 8.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ferozsons Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Ferozsons Laboratories (KAR:FEROZ) is currently considered Fairly Valued. The stock's GF Value™ is ₨419.78, compared to a current price of ₨391.89 — trading 6.6% below its estimated fair value. The current Pretax Margin % is 7.68%, which is 14% below median its 10-year median of 8.89 and 5.5% above the Drug Manufacturers industry median of 7.28. Ferozsons Laboratories' overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Ferozsons Laboratories (KAR:FEROZ), the current Pretax Margin % is 7.68% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ferozsons Laboratories (KAR:FEROZ) Overvalued in 2026?
Based on GuruFocus' analysis, Ferozsons Laboratories stock appears to be undervalued.
The current stock price of ₨391.89 is trading 6.6% below its estimated GF Value™ of ₨419.78.
GuruFocus considers Ferozsons Laboratories to be Fairly Valued.
Key valuation signals for KAR:FEROZ:
Pretax Margin %: 7.68% (14% below median its 10-year median of 8.89)
GF Value™: ₨419.78 vs. price of ₨391.89 (6.6% below fair value)
Industry Position: 5.5% above the Drug Manufacturers median (#432 of 961)
No single metric tells the full story. See the KAR:FEROZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ferozsons Laboratories Ltd is a pharmaceutical company. It is engaged in the import, manufacture, and sale of pharmaceuticals products and medical devices. The company operates in the therapeutic areas of dermatology, anti-infective treatments, gastroenterology, hepatology, cardiology, and diabetes. It manufactures tablets, capsules, syrups, suspensions, creams, and ointments. The company operates in three segments namely Ferozsons, BF Biosciences, and Others. The group sells its products in Pakistan and internationally, of which the majority of the revenue is generated from the sales made in Pakistan.
70GF Score
Get the complete analysis for KAR:FEROZ
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KAR:FEROZ has been successfully added to your 
